Educational Objectives

Following this program, participants should be able to:

Roundtable: Cancer as a Chronic Disease: What Should be Done to Serve Cancer Survivors in 2009 and Beyond?:
• Define “survivorship care plan” .
• List the benefits and drawbacks to implementing a survivorship care plan/
• Identify factors that prevent patients from returning to their primary care physician after treatment for cancer.
  NCCN Non-Small Cell Lung Cancer Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for non-small cell lung cancer.
• Identify updates to the NCCN Guidelines for non-small cell lung cancer.
  Advances in Minimally Invasive Surgery:
• List advances made in minimally invasive surgical techniques.
• Describe advantages and drawbacks to the use of minimally invasive surgical techniques.
  NCCN Colon and Rectal Cancers Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for colon and rectal cancers.
• Identify updates to the NCCN Guidelines for colon and rectal cancers.
  NCCN Pancreatic Adenocarcinoma Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for pancreatic cancer.
• Identify updates to the NCCN Guidelines for pancreatic cancer.
  NCCN Soft Tissue Sarcoma Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for soft tissue sarcoma.
• Identify updates to the NCCN Guidelines for soft tissue sarcoma.
  Roundtable: Finding and Achieving Value in Cancer Care:
• Identify the issues involved in finding and achieving value in cancer care.
  NCCN Task Force Report: Bone Health in Cancer Care:
• Summarize the findings of the NCCN Task Force for Bone Health in Cancer Care.
• Describe the pathophysiology, imaging techniques, and surgical management and management of bone pain related to metastases.
  NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated with EGFR Inhibition in Patients with Cancer:
• Summarize the findings of the NCCN Task Force for Management of Toxicity Associated with EGFR Inhibition in Patients with Cancer.
• Discuss the role dermatologic reactions can play in cancer treatment.
  NCCN Kidney Cancer Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for kidney cancer.
• Identify updates to the NCCN Guidelines for kidney cancer.
  NCCN Non-Hodgkin’s Lymphomas Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for non-Hodgkin’s lymphoma.
• Identify updates to the NCCN Guidelines for non-Hodgkin’s lymphoma.
  New NCCN Guidelines: Cutaneous B-cell Lymphoma:
• Explain how to integrate into professional practice the new NCCN Guidelines for cutaneous B-cell lymphoma.
• Summarize the recommendations for the management of cutaneous B-cell lymphoma based on the recently developed NCCN Guideline.
  NCCN Task Force Report: Tumor Markers in CML and Lymphomas:
• Summarize the findings of the NCCN Task Force for Tumor Markers in CML and Lymphomas.
• Describe various techniques used for the identification of tumor markers and chromosomal abnormalities, including their advantages and disadvantages.
  NCCN Breast Cancer Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for breast cancer.
• Identify updates to the NCCN Guidelines for breast cancer.
  NCCN Task Force Report: Integration of ER/PR Tumor Markers into Treatment Planning for Breast Cancer:
• Summarize the findings of the NCCN Task Force for Integration of ER/PR Tumor Markers into Treatment Planning for Breast Cancer.
• List the clinical evidence leading to the incorporation of the ER/PR biomarkers as both a prognostic and a predictive factor in the management of breast cancer.
  NCCN Oncology Outcomes Database Project:
• Explain the importance of building multidisciplinary care systems for cancer utilizing evidence, data and outcomes, and shared data platforms
  NCCN Ovarian Cancer Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for ovarian cancer.
• Identify updates to the NCCN Guidelines for ovarian cancer.
  NCCN Melanoma Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for melanoma.
• Identify updates to the NCCN Guidelines for melanoma.
  NCCN Thyroid Carcinoma Guidelines Update:
• Explain how to integrate into professional practice the NCCN Guidelines for thyroid cancer.
• Identify updates to the NCCN Guidelines for thyroid cancer.
  Advances in Radiation Treatment for Head and Neck Cancers:
• Identify current and emerging radiation techniques for the management of patients with head and neck cancers
  Sunday Brunch with the Experts: Considerations in Management of Antiemetic Therapy:
• Describe the factors that need to be evaluated for appropriate selection of antiemetic therapy.
• List the goals of effective antiemetic therapy.

These objectives are subject to change as agenda is finalized.

Last Update: 1/6/2009